The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males : the LIFESTAT study. / Asping, Magnus; Stride, Nis; Sogaard, Ditte; Dohlmann, Tine Lovso; Helge, Jorn W.; Dela, Flemming; Larsen, Steen.

I: European Journal of Clinical Pharmacology, Bind 73, Nr. 6, 06.2017, s. 679-687.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Asping, M, Stride, N, Sogaard, D, Dohlmann, TL, Helge, JW, Dela, F & Larsen, S 2017, 'The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study', European Journal of Clinical Pharmacology, bind 73, nr. 6, s. 679-687. https://doi.org/10.1007/s00228-017-2224-4

APA

Asping, M., Stride, N., Sogaard, D., Dohlmann, T. L., Helge, J. W., Dela, F., & Larsen, S. (2017). The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study. European Journal of Clinical Pharmacology, 73(6), 679-687. https://doi.org/10.1007/s00228-017-2224-4

Vancouver

Asping M, Stride N, Sogaard D, Dohlmann TL, Helge JW, Dela F o.a. The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study. European Journal of Clinical Pharmacology. 2017 jun.;73(6):679-687. https://doi.org/10.1007/s00228-017-2224-4

Author

Asping, Magnus ; Stride, Nis ; Sogaard, Ditte ; Dohlmann, Tine Lovso ; Helge, Jorn W. ; Dela, Flemming ; Larsen, Steen. / The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males : the LIFESTAT study. I: European Journal of Clinical Pharmacology. 2017 ; Bind 73, Nr. 6. s. 679-687.

Bibtex

@article{359c5709f19a4f23bc6cfa289eb2ffdb,
title = "The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study",
abstract = "BackgroundStatins are used to lower cholesterol in plasma and are one of the most used drugs in the world. Many statin users experience muscle pain, but the mechanisms are unknown at the moment. Many studies have hypothesized that mitochondrial function could be involved in these side effects.AimThe aim of the study was to investigate mitochondrial function after 2 weeks of treatment with simvastatin (S; n = 10) or pravastatin (P; n = 10) in healthy middle-aged participants.MethodsMitochondrial respiratory capacity and substrate sensitivity were measured in permeabilized muscle fibers by high-resolution respirometry. Mitochondrial content (citrate synthase (CS) activity), antioxidant content, as well as coenzyme Q10 concentration (Q10) were determined. Fasting plasma glucose and insulin concentrations were measured, and whole body maximal oxygen uptake (VO2max) was determined.ResultsNo differences were seen in mitochondrial respiratory capacity although a tendency was observed for a reduction when complex IV respiration was analyzed in both S (229 (169; 289 (95% confidence interval)) vs. 179 (146; 211) pmol/s/mg, respectively; P = 0.062) and P (214 (143; 285) vs. 162 (104; 220) pmol/s/mg, respectively; P = 0.053) after treatment. A tendency (1.64 (1.28; 2.00) vs. 1.28 (0.99; 1.58) mM, respectively; P = 0.092) for an increased mitochondrial substrate sensitivity (complex I-linked substrate; glutamate) was seen only in S after treatment. No differences were seen in Q10, CS activity, or antioxidant content after treatment. Fasting glucose and insulin as well as VO2max were not changed after treatment.ConclusionTwo weeks of statin (S or P) treatment have no major effect on mitochondrial function. The tendency for an increased mitochondrial substrate sensitivity after simvastatin treatment could be an early indication of the negative effects linked to statin treatment.",
keywords = "Human, Mitochondrial function, Side effects, Skeletal muscle, Statins",
author = "Magnus Asping and Nis Stride and Ditte Sogaard and Dohlmann, {Tine Lovso} and Helge, {Jorn W.} and Flemming Dela and Steen Larsen",
year = "2017",
month = jun,
doi = "10.1007/s00228-017-2224-4",
language = "English",
volume = "73",
pages = "679--687",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males

T2 - the LIFESTAT study

AU - Asping, Magnus

AU - Stride, Nis

AU - Sogaard, Ditte

AU - Dohlmann, Tine Lovso

AU - Helge, Jorn W.

AU - Dela, Flemming

AU - Larsen, Steen

PY - 2017/6

Y1 - 2017/6

N2 - BackgroundStatins are used to lower cholesterol in plasma and are one of the most used drugs in the world. Many statin users experience muscle pain, but the mechanisms are unknown at the moment. Many studies have hypothesized that mitochondrial function could be involved in these side effects.AimThe aim of the study was to investigate mitochondrial function after 2 weeks of treatment with simvastatin (S; n = 10) or pravastatin (P; n = 10) in healthy middle-aged participants.MethodsMitochondrial respiratory capacity and substrate sensitivity were measured in permeabilized muscle fibers by high-resolution respirometry. Mitochondrial content (citrate synthase (CS) activity), antioxidant content, as well as coenzyme Q10 concentration (Q10) were determined. Fasting plasma glucose and insulin concentrations were measured, and whole body maximal oxygen uptake (VO2max) was determined.ResultsNo differences were seen in mitochondrial respiratory capacity although a tendency was observed for a reduction when complex IV respiration was analyzed in both S (229 (169; 289 (95% confidence interval)) vs. 179 (146; 211) pmol/s/mg, respectively; P = 0.062) and P (214 (143; 285) vs. 162 (104; 220) pmol/s/mg, respectively; P = 0.053) after treatment. A tendency (1.64 (1.28; 2.00) vs. 1.28 (0.99; 1.58) mM, respectively; P = 0.092) for an increased mitochondrial substrate sensitivity (complex I-linked substrate; glutamate) was seen only in S after treatment. No differences were seen in Q10, CS activity, or antioxidant content after treatment. Fasting glucose and insulin as well as VO2max were not changed after treatment.ConclusionTwo weeks of statin (S or P) treatment have no major effect on mitochondrial function. The tendency for an increased mitochondrial substrate sensitivity after simvastatin treatment could be an early indication of the negative effects linked to statin treatment.

AB - BackgroundStatins are used to lower cholesterol in plasma and are one of the most used drugs in the world. Many statin users experience muscle pain, but the mechanisms are unknown at the moment. Many studies have hypothesized that mitochondrial function could be involved in these side effects.AimThe aim of the study was to investigate mitochondrial function after 2 weeks of treatment with simvastatin (S; n = 10) or pravastatin (P; n = 10) in healthy middle-aged participants.MethodsMitochondrial respiratory capacity and substrate sensitivity were measured in permeabilized muscle fibers by high-resolution respirometry. Mitochondrial content (citrate synthase (CS) activity), antioxidant content, as well as coenzyme Q10 concentration (Q10) were determined. Fasting plasma glucose and insulin concentrations were measured, and whole body maximal oxygen uptake (VO2max) was determined.ResultsNo differences were seen in mitochondrial respiratory capacity although a tendency was observed for a reduction when complex IV respiration was analyzed in both S (229 (169; 289 (95% confidence interval)) vs. 179 (146; 211) pmol/s/mg, respectively; P = 0.062) and P (214 (143; 285) vs. 162 (104; 220) pmol/s/mg, respectively; P = 0.053) after treatment. A tendency (1.64 (1.28; 2.00) vs. 1.28 (0.99; 1.58) mM, respectively; P = 0.092) for an increased mitochondrial substrate sensitivity (complex I-linked substrate; glutamate) was seen only in S after treatment. No differences were seen in Q10, CS activity, or antioxidant content after treatment. Fasting glucose and insulin as well as VO2max were not changed after treatment.ConclusionTwo weeks of statin (S or P) treatment have no major effect on mitochondrial function. The tendency for an increased mitochondrial substrate sensitivity after simvastatin treatment could be an early indication of the negative effects linked to statin treatment.

KW - Human

KW - Mitochondrial function

KW - Side effects

KW - Skeletal muscle

KW - Statins

U2 - 10.1007/s00228-017-2224-4

DO - 10.1007/s00228-017-2224-4

M3 - Journal article

C2 - 28246888

VL - 73

SP - 679

EP - 687

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 6

ER -

ID: 183825271